A

Artelo Biosciences

ARTL

Clinical-stage biopharmaceutical company (Nasdaq: ARTL)

Market Performance

Tokenized Assets

TickerExchangePrice24HSpreadLiquidity ±2%24H VolumeOIFundingMax LeverageFees